|
Q3 FY2025
As of Sep 27, 2025
|
Q2 FY2025
As of Jun 28, 2025
|
Q1 FY2025
As of Mar 29, 2025
|
Q4 FY2024
As of Dec 28, 2024
|
Q3 FY2024
As of Sep 28, 2024
|
Q2 FY2024
As of Jun 29, 2024
|
Q1 FY2024
As of Mar 30, 2024
|
Q4 FY2023
As of Dec 30, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jul 1, 2023
|
Q1 FY2023
As of Apr 1, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Oct 1, 2022
|
Q2 FY2022
As of Jul 2, 2022
|
Q1 FY2022
As of Apr 2, 2022
|
Q4 FY2021
As of Jan 1, 2022
|
Q3 FY2021
As of Oct 2, 2021
|
Q2 FY2021
As of Jul 3, 2021
|
Q1 FY2021
As of Apr 3, 2021
|
Q4 FY2020
As of Jan 2, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trade accounts receivable, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Current assets held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, net | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Trademarks and other identifiable intangibles, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other noncurrent assets | ||||||||||||||||||||
| Noncurrent assets held for sale | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Payroll and employee benefits | ||||||||||||||||||||
| Advertising and promotion | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Accounts Receivable Securitization Facility | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Current liabilities held for sale | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Lease liabilities - noncurrent | ||||||||||||||||||||
| Pension and postretirement benefits | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Noncurrent liabilities held for sale | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock (50,000,000 authorized shares; $.01 par value) Issued and outstanding - None | ||||||||||||||||||||
| Common stock (2,000,000,000 authorized shares; $.01 par value) Issued and outstanding - 353,802,157, 352,541,826 and 351,779,995, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
